- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06571721
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
August 26, 2024 updated by: Integrative Skin Science and Research
Prospective, Double-Blinded, Randomized Study of Topical Almond Oil and Tretinoin on Facial Wrinkles
Investigate the topical use of almond oil, almond oil augmented with 0.5% vitamin E, 0.025% tretinoin oil augmented with castor oil on the appearance of facial fine lines and wrinkles, pigmentation, hydration, trans-epidermal water loss, and sebum excretion rate.
Study Overview
Status
Recruiting
Detailed Description
The natural cosmetic market is a multi-billion dollar industry.
Nutraceuticals and food-based cosmetics are a growing trend within dermatology.
Almonds are a rich dietary source of a range of fatty acids, phytochemical polyphenols, and antioxidants.
Our previous study was a double blinded study that compared almond consumption interventions to a calorie matched intervention over 16 weeks.
The study determined that that there was a statistically significant 8.41% improvement in wrinkle severity in the women that received almond supplementation.
This proposal aims to now understand how the topical application of almond oil may influence the appearance of wrinkles and facial tone in post-menopausal women.
Almond oil is rich in fatty acids and alpha-tocopherol.
Tocopherol inhibits melanogenesis in melanocytes and topical alpha tocopherol has been shown to improve skin antioxidants and hyperpigmentation.
A challenge of almond oil is that it is prone to oxidation due to its high unsaturated fatty acid concentrations.
However, tocopherol has also been shown to improve almond oil stability.
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nasima Afzal
- Phone Number: 915-750-2463
- Email: nasima@integrativeskinresearch.com
Study Locations
-
-
California
-
Sacramento, California, United States, 95819
- Recruiting
- Integrative Research Institute
-
Contact:
- Nasima Afzal
- Phone Number: 915-750-2463
- Email: nasima@integrativeskinresearch.com
-
Contact:
- Sarah Adnan
- Phone Number: 9157502463
- Email: sarah@integrativeskinresearch.com
-
Principal Investigator:
- Raja Sivamani, MD
-
Sub-Investigator:
- Rubaina Dang, ND
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Post-menopausal women of Fitzpatrick skin types 1, 2, and 3
- Individuals with facial fine lines and wrinkles
Exclusion Criteria:
- Individuals who are pregnant or breastfeeding
- Prisoners
- Adults unable to consent
- Those with a nut allergy or tocopherol allergy
- Current smokers, those that have smoked within the past year, and former smokers with greater than a 10-pack- year history of smoking
- Those with an autoimmune photosensitive condition or a known genetic condition with a deficiency in collagen production (such as Ehlers-Danlos syndromes)
- Those who have undergone any cosmetic procedures to the face in the 3 months prior to enrollment in the opinion of the investigator. People that have undergone deeper chemical peels (TCA based peels) within 1 year prior to enrollment
- Individuals who are unwilling to discontinue vitamin E containing supplements and food sources such as all nuts, sunflower seeds or sunflower oil during the washout and intervention
- Individual who are unwilling to discontinue topical cosmetic products during the duration of the study or unwilling to undergo a 2-week washout of topicals that are known to modulate collagen and pigment:
- Retinoids such as tretinoin, adapalene, retinol, except as provided by the study.
- Antioxidant ingredients such as vitamin C or vitamin E.
- Pigment reducing agents such as hydroquinone, azelaic acid, kojic acid, or a retinoid except for the retinol that is provided in this study.
- Topicals that contain a nut oil or nut extract as part of their ingredient list.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Almond Oil
Almond Oil.
1-2 Drops of randomized topical product will be applied on entire face nightly.
Duration: 16 weeks
|
1-2 Drops of randomized topical product will be applied on entire face nightly.
|
|
Experimental: Almond oil augmented with 0.5% Vitamin E
Almond oil augmented with 0.5% Vitamin E. 1-2 Drops of randomized topical product will be applied on entire face nightly.
Duration: 16 weeks
|
1-2 Drops of randomized topical product will be applied on entire face nightly.
|
|
Experimental: 0.025% Tretinoin oil augmented with castor oil
0.025% Tretinoin oil augmented with castor oil.
1-2 Drops of randomized topical product will be applied on entire face nightly.
Duration: 16 weeks
|
1-2 Drops of randomized topical product will be applied on entire face nightly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Facial wrinkles
Time Frame: 16 Weeks
|
Change in severity of wrinkles measured by photographic analysis (BTBP 3D Camera System)
|
16 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Pigment intensity through the use of high resolution photography (BTBP Clarity Pro)
Time Frame: 16 Weeks
|
Change in the appearance of facial pigmentation by high resolution photography (BTBP Clarity Pro) and measures intensity of facial pigmentation.
Higher scores indicate darker pigmentation.
|
16 Weeks
|
|
Changes in skin hydration
Time Frame: 16 Weeks
|
Change in skin hydration will be measured on both cheeks through the use of a non-invasive device known as the Moisturemeter.
|
16 Weeks
|
|
Sebum excretion rate
Time Frame: 16 Weeks
|
Measure of skin sebum via sebumeter
|
16 Weeks
|
|
Transepidermal water loss
Time Frame: 16 Weeks
|
Change in transepidermal water loss (TEWL) using the Vapometer
|
16 Weeks
|
|
Pigment intensity measured through SkinColorCatch.
Time Frame: 16 Weeks
|
Change in the appearance of facial pigmentation will be measured on both cheeks through the use of a handheld device known as the SkinColorCatch with quantitative output for pigment intensity.
|
16 Weeks
|
|
Tolerability Assessment Questionnaire
Time Frame: 16 Weeks
|
A 6 question survey based on the self-assessment about the tolerability of the topical skin product.
The scale ranges from 0-3 with 0 being the best outcome possible and with 3 being the worst.
"0" as none, "1" as mild, "2" as moderate, or "3" as severe.
|
16 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 22, 2024
Primary Completion (Estimated)
January 22, 2025
Study Completion (Estimated)
July 22, 2025
Study Registration Dates
First Submitted
August 23, 2024
First Submitted That Met QC Criteria
August 23, 2024
First Posted (Actual)
August 26, 2024
Study Record Updates
Last Update Posted (Actual)
August 28, 2024
Last Update Submitted That Met QC Criteria
August 26, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Skin Diseases
- Congenital Abnormalities
- Hematologic Diseases
- Hemorrhagic Disorders
- Genetic Diseases, Inborn
- Connective Tissue Diseases
- Hemostatic Disorders
- Skin Diseases, Genetic
- Skin Abnormalities
- Collagen Diseases
- Ehlers-Danlos Syndrome
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Antineoplastic Agents
- Gastrointestinal Agents
- Protective Agents
- Dermatologic Agents
- Micronutrients
- Vitamins
- Keratolytic Agents
- Antioxidants
- Cathartics
- Vitamin E
- Tretinoin
- Castor Oil
Other Study ID Numbers
- IRI24_01_AlmondOil
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wrinkle
-
Physicians Laser and Dermatology InstituteRecruiting
-
Shanghai Dermatology HospitalRecruiting
-
Integrative Skin Science and ResearchActera (Sponsor)Completed
-
Cynosure, Inc.Terminated
-
Saie BeautyCompleted
-
Innate srl1MedRecruiting
-
Croma-Pharma GmbHActive, not recruiting
-
Amazentis SAPrinceton Consumer ResearchCompleted
-
HaEmek Medical Center, IsraelUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Universitair Medical Centrum GroningenNot yet recruiting
Clinical Trials on Topical Product: Almond Oil
-
University Hospital, ToulouseNot yet recruitingPain | Complementary Therapies | Aromatherapy | Postoperative Recovery | Thoracic Surgical Procedures
-
Semanur BilgiçNot yet recruitingCancerTurkey (Türkiye)
-
Stony Brook UniversitySuspendedBack Pain | Sciatica | Back Pain, LowUnited States
-
University of Sao PauloActive, not recruitingLabor Pain and AnxietyBrazil
-
University of California, DavisRecruiting
-
Bilecik Seyh Edebali UniversitesiEskisehir Osmangazi UniversityEnrolling by invitationFibromyalgia | Cost | AromatherapyTurkey (Türkiye)
-
University of BaghdadNot yet recruitingRheumatoid Arthritis (RA)
-
Jordan University of Science and TechnologyCompleted
-
MetroHealth Medical CenterCompletedPain | Low Back Pain | Procedural Pain | Procedural AnxietyUnited States
-
Henry Ford Health SystemAllerganCompletedPigmentationUnited States